SCHEMBL7490686

SCHEMBL7490686

CC(C)(C)[Si](Oc1cccc2c1CCCC2N1CCC1c1nc(-c2ccccc2)c(-c2ccccc2)o1)(c1ccccc1)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 7/20 0.60
SIGMAR1 Q99720 1/20 0.35
NR4A2 P43354 2/20 0.32
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
RXRG P48443 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7488572 0.97 PTGIR (0.64) PTGIRSIGMAR1NR4A2RXRARXRB
SCHEMBL7498821 0.97 PTGIR (0.64) PTGIRSIGMAR1NR4A2RXRARXRB
SCHEMBL7493431 0.97 PTGIR (0.64) PTGIRSIGMAR1NR4A2RXRARXRB
SCHEMBL7487288 0.97 PTGIR (0.64) PTGIRSIGMAR1NR4A2RXRARXRB
SCHEMBL7487492 0.96 PTGIR (0.61) PTGIRSIGMAR1NR4A2RXRARXRB
SCHEMBL7488099 0.92 PTGIR (0.59) PTGIRSIGMAR1
SCHEMBL7483903 0.88 PTGIR (0.51) PTGIRSIGMAR1NR4A2RXRARXRB
SCHEMBL7487040 0.85 PTGIR (0.52) PTGIRNR4A2RXRARXRBRXRG
SCHEMBL7490579 0.84 PTGIR (0.47) PTGIRNR4A2RXRARXRBRXRG
SCHEMBL7494714 0.83 PTGIR (0.72) PTGIRSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0842161-B1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2002-09-18 EP disclosed
EP-1213285-A2 4,5-dipheny-oxazole derivatives and their use as platelet aggregation inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-12 EP disclosed
US-6300344-B1 FOR THERAPEUTIC AND/OR PROPHYLACTIC TREATMENT OF ARTERIAL OBSTRUCTION, CEREBROVASCULAR DISEASE, HEPATIC CIRRHOSIS, ARTERIOSCLEROSIS, ISCHEMIC HEART DISEASE, RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, HYPERTENSION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 US disclosed
US-5972965-A USEFUL FOR INHIBITION OF PLATELET AGGREGATION, VASODILATION, ANTIHYPERTENSIVE ACTIVITY AND PROSTAGLANDIN AGONIST FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-26 US disclosed
EP-0842161-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-05-20 EP disclosed